Findings from large-scale epidemiological studies, such as the Diabetes Control Complication Trial (DCCT) [2,3] and the Kumamoto Study [4], clearly demonstrate that intensive insulin therapy significantly reduces the incidence of diabetic complications as well as prevents disease progression in type 1 and type 2 diabetic patients compared to conventional insulin therapy. This evidence concerns the gene INS and diabetes mellitus.